A few years ago, Jennifer Davagian Ensign was a master seamstress, running a custom interior design business in Sudbury. Today, she's the CEO of a Concord-based medical device company that holds patents in the U.S. and abroad, with the latest patent award coming from the Japanese Patent Office.
She's not just running the company. She designed the chief product, Sephure. It's a suppository applicator for people with digestive conditions and other illness, from migraine headaches to malaria, and one she designed in her own kitchen after teaching herself the basics of silicon molding.
Generex Biotechnology Corp. of Worcester, a developer of drug delivery technology, said it has entered into an agreement with Canadian medical marijuana development firm CannScience Innovations Inc. to license its drug delivery system for delivery of medical marijuana products.
Federal prosecutors have charged two former pharmacists with second-degree murder for allegedly allowing dirty conditions at a Framingham pharmacy that produced contaminated steroids that killed dozens of people around the country.
Edward J. Kelly, the president of Milford Regional Medical Center, will also become the CEO of the health care organization in 2016, Milford Regional announced Thursday.
The heads of several major hospitals are calling on Gov. Deval Patrick and legislative leaders to undo $33.3 million in spending cuts made last month by the governor, saying the reductions add pressure on a "vulnerable" system marked by two recent hospital closings.
Framingham biotech firm Boston Heart Diagnostics will be purchased by Eurofins Scientific of Luxembourg for $140 million, the company announced Monday.
The Affordable Care Act impacts health care providers of all types, but dentists were largely disappointed by its shortcomings in expanding dental coverage.
Jobs and payroll levels are up substantially across the United States in the ambulatory health services industry, which includes outpatient services, physician and dentist offices, and home health care and medical labs, according to U.S. Census Bureau data released Tuesday.
UMass Memorial Health Care (UMMHC) will post a $29 million operating surplus in fiscal 2014, according to preliminary results the Worcester-based health care system shared with bond investors this week.